Discontinuation report APO-NEVIRAPINE XR

Last updated on 2019-03-11 History
Report ID 78257
Drug Identification Number 02427931
Brand name APO-NEVIRAPINE XR
Common or Proper name NEVIRAPINE
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) NEVIRAPINE
Strength(s) 400MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 30 BLS
ATC code J05AG
ATC description DIRECT ACTING ANTIVIRALS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2019-03-08
Remaining supply date 2019-03-08
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2019-03-11 French Compare
v1 2019-03-11 English Compare